Skip to main content
. 2022 Aug 26;24:57. doi: 10.1186/s13058-022-01555-7

Fig. 3.

Fig. 3

Kaplan‒Meier curve of progression-free survival (PFS) according to heterogeneity determined by 18F-FES PET. A PFS predicted by interlesional heterogeneity, with patients stratified by the presence or absence of 18F-FES-negative lesions in the whole cohort. B PFS predicted by intralesional heterogeneity, with patients stratified by the median FES-HI in the subgroup cohort with only 18F-FES-positive lesions